Large-scale testing (Phase 3)Study completedNCT01379937
What this trial is testing
Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children
Who this might be right for
Influenza
GlaxoSmithKline 520